Mood instability may be causally associated with the high risk of cardiovascular disease: evidence from a mendelian randomization analysis

Zirui Liu, Haocheng Wang, Zhengkai Yang, Yu Lu, Jikai Wang, Cao Zou
doi: https://doi.org/10.1101/2023.08.29.23294761

Abstract

Background Mental illness was identified associated with high risk of cardiovascular diseases (CVDs). However, few studies focused on the effect of personality traits, the causal relationships remain unknown. Here, we use mendelian randomization (MR) analyses to evaluate the causal association between mood instability (mood swings) and 5 common CVDs.

Methods Large genome-wide association studies (GWAS) of mood swings (n= 373733) and 5 CVDs from two independent cohorts respectively including coronary artery disease (CAD) (n= 766053), myocardial infarction (MI) (n= 596436), heart failure (HF) (n= 1185501), atrial fibrillation (AF) (n= 2169833) and stroke (n = 627558). We performed a range of bidirectional two-sample MR and related sensitive analysis including MR-Egger regression, MR-PRESSO global test and “Leave-one-out” method. A Bonferroni-corrected significance level of p < 0.01 (0.05/5) was identified to be statistically significant, while p < 0.05 was considered to indicate suggestive evidence. Moreover, multivariable MR (MVMR) and mediation analyses were also conducted to adjust confounding factors as well as found potential mediators.

Results This MR analyses revealed the significant causal effects of mood swings on CAD (OR = 1.45, 95% CI 1.24–1.71; P = 5.52e-6), MI (OR = 1.60, 95% CI 1.32–1.95; P = 1.77e-6), HF (OR = 1.42, 95% CI 1.12–1.71; P = 2.32e-6) and stroke (OR = 1.48, 95% CI 1.19–1.83; P = 3.46e-4). However, no causal effects of mood swings on AF (P=0.16) were found. In the reverse MR, no causal relationships were observed. Additionally, hypertension may mediate the causal pathway from mood swings to CAD (proportion of mediation effect in total effect: 39.60%, 95% CI: 19.31%–59.89%), MI (35.37%, 95% CI: 17.10%–53.65%), HF (43.19%, 95% CI: 20.68%–65.69%) and stroke (55.47%, 95% CI: 27.00%–83.95%).

Conclusion Mood instability (mood swings) causally resulted in CAD, MI, HF and stroke, and these causal effects may be partly mediated by hypertension.

1. Introduction

Mood instability, a personality trait presents in normal individuals, is defined as a frequent, sudden and unpredictable alteration in emotional states1. Mood instability is relatively common in the general crowd—approximately 45% participants in the UK biobank (n=488105) admitted that they experience frequent fluctuations in their emotional state2, such as anger transitions into sadness or anxiety, excitement to disinterest, or happiness turns into tearful sorrow. Although mood instability is not a psychotic disorder, many studies have identified its tight association with mental illness including major depressive disorder (MDD), bipolar disorder (BD), schizophrenia and anxiety disorder3-5.

Numerous research has focused on the relationship between psychotic illness and common cardiovascular diseases (CVD) such as coronary artery disease (CAD), atrial fibrillation (AF), heart failure (HF), myocardial infarction (MI) and stroke. Similar conclusions were drawn from different studies that psychotic illness could not only increase the risk of CVD, but also be associated with high risk of all-cause and cardiovascular disease mortality6-9. However, limited studies focused on the relationship between personality traits (such as mood instability) and CVD.

In contrast to psychotic disorders that are usually late onset, after birth personality traits start to exert a sustaining influence on people’s behaviors and biological processes10, which may play an essential role in the progress of CVD. So, we hypothesize that mood instability as an upstream factor for psychotic disorders may exert a profound impact on the progress of CVD. Yaa A. Kwapong11 et al. used “poor mental health days (PMHD)” to assessment the potential relationship between PMH and CVD. Although they found that more PMHD brought more risk of CVD to participants, this cross-sectional study cannot provide any causal relationship or the directionality of the association.

Mendelian randomization (MR) is a method employing genetic variants as instrumental variables (IVs) to verify whether exiting a causal relationship between exposures and outcomes12, which based on the principle of gene random segregation and independent assortment during the process of meiosis13. Because MR is not affected by environmental factors, it effectively avoids confounding factors and reverse causality, which are always inevitable in observation studies14. Recent MR studies have focused on the causal effect from mental illness to CVD9,15,16, fully clarifying the viewpoint that the risk of CVD is significantly higher than those without psychotic disorder. However, whether mood instability may causally associate with the high risk of CVD is still unknown.

In this article, we preformed the first bidirectional two-sample MR analysis to investigate the causal association between mood instability and 5 common CVDs, including CAD, MI, HF, AF, and stroke by using genome-wide association studies (GWAS). Two independent cohorts were estimated and pooled to ensure the robustness of the casual effects. Additionally, we further explored whether the casual relationships of mood instability on CVDs is mediated by hypertension by using mediation MR analysis.

2. Materials and methods

2.1 Study design

In this study, we use the bidirectional two-sample MR method to clarify the casual relationships between mood instability and 5 common CVDs with GWAS summary statistics. In addition, we conducted multivariable MR (MVMR) and mediation MR analysis to eliminating the influence of confounding factors and investigate whether any regular risk factors of CVD, such as smoking, drinking, body mass index (BMI), Interleukin-6 (IL-6), C-reactive protein (CRP) and hypertension may mediate the casual effect. The framework of this study was shown in Figure 1.

Figure 1.
Figure 1.

Study design of MR study

All statistics were calculated using R software 4.2.2 (The R Foundation for Statistical Computing).

2.2 Genetic association datasets for bidirectional MR analysis

All the single nucleotide polymorphisms (SNPs) used in this MR study as IVs must satisfy the following 3 core assumptions: 1) genetic IVs are robustly associated with exposures; 2) no confounders are associated with IVs; 3) IVs affect outcomes only by their effects on exposures rather than other pathways. (Figure S1). All the summary statistics were publicly available which obtained from the Open GWAS database developed by the MRC Integrative Epidemiology Unit (IEU) (https://gwasmrcieu.ac.uk/). As all individual studies that contributed to this MR study had obtained the necessary consent and ethics approvals, no additional consent or ethics approval was specifically required.

We selected valid SNPs for this study based on the required MR. Firstly, all SNPs robustly associated with exposures (p < 5e-8) were extracted as candidate IVs. Secondly, we used linkage disequilibrium analysis to obtain independent SNPs (kb = 10,000, r2 < 0.001). Thirdly, the F-statistic was calculated for each SNP to avoid “weak instrument” bias (F > 10), the formula is: Embedded Image where, n, k, R2 represents sample size, the number of SNPs and the variance explained by the instruments respectively17. Finally, according to the Bonferroni multiple correction criterion, p < 0.01(0.05/5) was significant, 0.01 < p < 0.05 was considered a potential casual association between exposure and outcome.

2.2.1 Genetic association datasets for mood instability

For mood instability, this study used “mood swings” large-scale GWAS summary statistics, which included 373,733 individuals in UK biobank and focused on 12 neuroticism items18.

2.2.2 Genetic association datasets for CVDs

Summary-level data for patients with 5 common CVDs were extracted from the EBI database.

To guarantee the homogeneity of the study population and the reliability of the results, each cardiovascular disease (CVD) was derived from two independent large-scale cohorts. So, we also extracted summary-level data for each CVD from the FinnGen consortium (https://www.finngen.fi/en). All the detailed information were shown in Table 1.

View this table:
Table 1. Detailed information from GWAS database.

2.3 Statistical analysis

The “TwoSampleMR” package24 was used for estimating the casual effects between mood instability and CVDs. The effects were represented by odds ratios (OR) with 95% confidence intervals (CI). Furthermore, we detected and removed outliers by using the “MR-PRESSO” package. The influence of confounding factors was eliminating by using “MendelianRandomization” package25, which can also be used for performing mediation analysis.

2.3.1 Univariable MR analysis

In the univariable MR analysis, we used the classical random effect inverse variance weighted method (IVW)26 to estimate causal effect between mood instability and different CVD events. Because the horizontal pleiotropy always exists in IVW estimates, we also employed two alternative methods including MR-Egger regression27 and Weighted median28 for MR analysis to evaluate the robustness of these outcomes. Causal effects were significant if the p value was less than the Bonferroni-corrected threshold (p<0.05/5=0.001) in IVW as well as the direction of these results from the weighted median and MR-Egger were consistent. P < 0.05 but above the threshold was defined as potential causal associations. Then, three complementary methods including MR-Egger intercept, MR-PRESSO (MR Pleiotropy Residual Sum and Outlier)29 and Leave-one-out were conducted as sensitive analysis. The MR-PRESSO could recognize potential outlier SNPs (p < 0.05) and correct them before re-estimating the causal effects to examine whether the causal effects would change after removing these outliers. Moreover, the Leave-one-out method was also conducted for evaluating the robustness of the univariable MR analysis outcomes through outlier SNPs. Additionally, for ensuring the homogeneity and reliabilities of these results, we pooled the outcomes from two independent large-scale cohort by means of meta-analysis.

2.3.2 Multivariable MR (MVMR)

We performed MVMR for those significant causal relationships which were identified in the univariable MR analysis to examine whether the outcomes were still significant when eliminating common confounding factors in CVDs (including smoking, drinking, BMI as well as hypertension) by using MVMR-IVW method. If MVMR reveals that any risk factors significantly attenuate the causal effects between mood instability and CVDs (P < 0.005 altered to P > 0.05), it will identify the risk factor as a mediating factor and the mediation effects will be estimated in mediation analysis.

2.3.3 Mediation analysis

Considering that mood instability could cause a range of somatic discomfort symptoms1 and previous observational studies have found that hypertension may mediate the pathway to different CVD events6,11,30,31, we performed the mediation analysis through the two-step MR method32.

Furthermore, any risk factor suggested as a mediation factor in MVMR will also be calculated mediation effects. In the first step, we calculated the causal effect of mood instability on mediators (β1), while in the second step, we estimated the causal effect of mediators on various CVDs (β2). The statistical significance of the mediating effects (β1*β2) as well as the proportion of the mediation effect in relation to the overall effect were estimated employing the delta method.

3. Outcomes

3.1 Primary analysis

3.1.1 Causal association between mood instability and 5 common CVDs

Firstly, we investigated the causal effect of genetically predicted mood instability on CAD, MI, HF, AF and stroke. The IVW method provided the primary results, which showed that mood instability was strongly associated with CAD (OR = 1.45, 95% CI 1.24–1.71; P = 5.52e-6), MI (OR = 1.60, 95% CI 1.32–1.95; P = 1.77e-6), HF (OR = 1.42, 95% CI 1.12–1.71; P = 2.32e-6) and stroke (OR = 1.48, 95% CI 1.19–1.83; P = 3.46e-4). However, causal effect of mood instability on AF was not significant in the primary analysis. Table 2 presented the outcomes of these results.

View this table:
Table 2. Outcomes about causal effects of mood instability (mood swings) on different CVDs

Additionally, we also tried to find any genetically predicted casual effects of different cardiovascular events on mood instability. However, no significant results were shown and these results could be found in Table S1.

3.1.2 Robustness of primary analysis

Using the MR-Egger regression and Weighted median method, the results were consistent with IVW method, which identified the reliability of the primary analysis.

There were no horizontal pleiotropic effects in MR-Egger intercept (Figure 2a-d) and no single SNP could determine the total causal effects of mood instability on CAD, MI, HF and stroke by using “Leave-one-out” method (Figure 2e-h). MR-PRESSO identified several outlier SNPs in different CVDs respectively (Table S2). After correcting these outliers, significant results were observed in these four CVD events.

Figure 2.
Figure 2.

Sensitive analysis about the causal effects of mood instability on different CVDs. Figure 2a-d are scatter plots and each plots represents an IV. The line on each point reflects the 95% CI, and the vertical coordinate is the effect of SNPs on (a) CAD, (b) stroke, (c) HF and (d) MI. The horizontal coordinate is the effect of SNPs on mood swings. The slope of the line corresponds to the causal estimation. A positive slope indicates that mood swings had a positive effect on cardiovascular events. Figure 2e-h are “Leave-one-out” graphs demonstrate that all lines were situated towards the positive side of the “0 line”, suggesting that the removal of any SNPs did not significantly impact the findings including (e) CAD, (f) stroke, (g) HF and (h) MI, implying the robustness of MR results. CVD, cardiovascular disease; IV, instrumental variable; CI, confidence interval; SNP, single nucleotide polymorphism; MI, myocardial infarction; HF, heart failure; CAD, coronary artery disease; MR, mendelian randomization.

3.2 MVMR analysis

MVMR was employed for significant outcomes in primary analysis to further investigate the effect of potential confounding factors on causal estimates33. In most cases, the causal effects of mood instability on 5 CVDs were remarkably robust (Table 3). However, after adjusting hypertension, the causal estimates were not significant in all circumstances, which suggested that hypertension may play an important role in the pathway from mood instability to CVDs.

View this table:
Table 3.

MVMR outcomes

3.3 Mediation analysis

Our findings identified that hypertension played a role in the causal effect of mood instability on CAD, MI, HF and stroke. The proportions of mediation were shown in Table 4. However, other potential mediators such as IL-6 and CRP have no such mediation effect.

View this table:
Table 4.

Mediation analysis outcomes

4. Discussion

In this MR study, we explored the causal relationships between mood instability and 5 high-frequency CVDs by using large-scale and open GWAS statistics. Three main findings were yield: Firstly, mood instability has a significant causal effect on a wide range of CVDs including CAD, MI, HF and stroke, which has been identified robust in sensitive analysis. However, no evidence claimed that mood instability could increase the risk of AF. Secondly, in most cases, common risk factors of CVD could not affect this causal effect, emphasizing the profound influence caused by mood instability. Thirdly, complementary analysis indicated hypertension may play an important role in the causal pathway of mood instability to CAD, MI, HF and stroke. Finally, we did not observe any statistically significant results in the reverse MR analysis.

Personality traits, especially mood instability (mood swings), which start to have an enduring impact from birth, the causal relationship to cardiovascular events are rarely investigated. Many researches have found MDD, anxiety disorder and bipolar disorder may accelerate the progression of CVD. A meta-analysis including 26 studies of 1,957,621 individuals revealed that depression increased the risk of stroke (HR 1.13; 95% CI 1.00-1.28), MI (HR 1.28; 95% CI, 1.14-1.45), HF (HR 1.04; 95% CI, 1.00-1.09) as well as the risk of cardiovascular morality (HR 1.44; 95% CI, 1.27-1.63)6. In the China Kadoorie Biobank (CKB) cohort study involving 512,712 persons, depression significantly increased CVD mortality (HR, 1.39 95%CI, 1.10-1.76), especially in male8. Previously two-sample mendelian randomization analysis conducted by Lei Wang9 et al. found the potential causal relationship between depression and AF (OR = 1.098, 95% CI 1.000–1.206; P = 0.049). Another MR study found mood disorders (MDD and BD) causally resulted in both stroke (OR 1.07; 95% CI 1.03–1.11) and ischemic stroke (OR 1.09; 95% CI 1.04–1.13)16. A cohort study conducted by Shinya Nakada et al. demonstrated that the risk of CVD among patients with anxiety disorder was higher than those without mental illness (HR 1.72; 95% CI 1.32–2.24)7. Similarly, the prevalence of CVD is significantly greater among BD patients than controls (OR 4.95; 95% CI 4.27–5.75)34. Several MR studies focused on the causal association between neuroticism and CVD draw negative results. Gull Rukh et al.35 found neuroticism could not increase the risk of any CVD traits (p>0.05). Among diabetes mellitus individuals, neuroticism also has no causal effects on CAD15. To best of our knowledge, this is the first study using MR to investigate the causal association between mood instability and different cardiovascular endpoints. Furthermore, these significant results clarified not only mental illness, but also personality traits could render a considerable powerful impact on circulatory system.

However, the pathophysiological mechanisms connecting mood swings to the progression of CVD is still unclear. Here, we proposed three potential mechanisms about how mood instability contributes to the development of CVDs. Firstly, psychiatric traits are associated with oxidative stress36. During the process of oxidative stress, total bilirubin (TBil) plays a vital role in antioxidant activity and cellular protection37. Mood instability may decrease TBil level and the lack of TBil brings to the damage to vascular endothelial cells, leads to hypertension in the end38. Persistent hypertension causes artery atherosclerosis and myocardial remodeling, which increase the risk of cardiovascular events. Interestingly, mood instability can cause hypertension, which is consistent with the result in our mediation analysis. Secondly, mood instability causes dysregulation of endocrine function. Glucocorticoids can reduce inflammation under a normal condition. However, long-term emotional instability can lead to abnormal secretion of glucocorticoids. Under the inhibition of high-concentration glucocorticoids, the immune system becomes insensitive, leading to an increased susceptibility to CVDs39. Thirdly, mood instability can lead to mental stress40, and studies have identified that cardiac sympathetic nerves can be abnormally activated during long-term mental stress, which can decrease the blood flow, increase heart rate and cause ventricular hypertrophy, leading to CVDs6,41.

Given that mood instability, this personality trait is an upstream factor to mental illness and have significant causal effects on CVDs, a focus on early recognition and management of mood swings may potentially lower the incidence of both psychotic disorder and cardiovascular disease. Although there is no direct evidence identified this hypothesis, some randomized controlled trails (RCT) aiming at depression and CVDs have draw some conclusion. They found that using selective serotonin reuptake inhibitors (SSRIs) in CAD patients with depressive symptoms was safe and effective 42,43. However, further researches are needed to clarify whether an early intervention to mood instability can change cardiovascular outcomes. Additionally, as mood instability is a very common personality trait among normal crowds, it may be necessary for clinicians to evaluate mental health at regular intervals by using questionnaire such as Mood Zoom (MZ),which has been proved a standard measurement for depression, anxiety and mental health44. Furthermore, a recent RCT demonstrated that stress related disorders were strongly associated with early onset CVD45, and regular exercise seems very important for releasing pressure as well as lowering the risk of CVD30,31. So besides regular screening, encouraging people with mood instability to exercise is also meaningful. Moreover, Niall M. McGowan46 further explored the relationship between mood instability and blood pressure (BP), they found BP may be a valuable predictor of mood instability, which emphasized the importance of Home blood pressure monitoring (HBPM) at regular intervals. The management of BP is likely to become a potential explicit treatment target for both improving unhealthy emotion and preventing CVDs.

Still, further studies remain to be conducted to develop a more comprehensive model for the management of physical and mental illnesses.

Our novel MR study had several strengths. As mentioned above, this study is the first to comprehensively estimate the casual relationship between mood instability (mood swings) and a wide range of cardiovascular endpoints. Additionally, for CVDs, two representative and independent cohorts were employed to ensure the causal results stable. Furthermore, most of SNPs have passed F-test (F>10), which showed a strength to be IVs for exposure. Then, we used various of methods for sensitive analysis and identified the robustness of our outcomes. Moreover, in order to eliminate common confounding factors which may affect the direction of causal results, we conducted complementary analysis by means of MVMR and mediation MR. Ultimately, we found hypertension mediated the causal effects from mood instability to CVDs, so we further investigated relevant mechanisms for clinical reference.

Some limitations can not be ignored. Firstly, statistics utilized in this study was from European ancestry, which constrained further extrapolation of the results to other racial groups. Secondly, we only selected one personality trait in this MR study, and other traits need to be included in the further studies. Thirdly, there may still be some unrecognized pathways between the exposure and outcome variables, potentially introducing biases into our results.

5. Conclusion

In conclusion, this bidirectional two-sample MR analysis is the earliest study to identify that mood instability has significant causal effects on CVDs including CAD, MI, HF and stroke, which can be partly mediated by hypertension. Enhancing emotional management and controlling blood pressure may be beneficial for decreasing the risk of CVDs, which need more support of evidence-based medicine.

Data Availability

All data produced in the present study are available upon reasonable request to the authors All data produced in the present work are contained in the manuscript All data produced are available online at https://gwasmrcieu.ac.uk/

6. Declarations

6.1 Ethics approval and consent to participate

Not applicable.

6.2 Consent for publication

Not applicable.

6.3 Availability of data and materials

All data generated or analysed during this study are included in this article and its supplementary information files.

6.4 Competing interests

The authors declare that they have no competing interests.

7. Fundings

The study was funded by the Suzhou Science and Technology Project (SKYD2022103), Suzhou Specialized Program for Diagnosis and Treatment Techniques of Clinical Key Diseases (LCZX202103), and Soochow University (P112206422).

8. Supplementary materials

Additional file 1, Table S1, Causal associations of CVDs on mood instability; Figure S1. Study design and 3 assumptions of MR analysis. Table S2. MR-PRESSO global test of primary analysis.

9. References

  1. 1.↵
    Fristad MA. Editorial: Mood Instability: What It Is, Why It Matters, and What to Do About It. J Am Acad Child Adolesc Psychiatry. 2022;61(10):1224–1226.
    OpenUrl
  2. 2.↵
    Rusk N. The UK Biobank. Nature Methods. 2018;15(12):1001–1001.
    OpenUrl
  3. 3.↵
    Balbuena L, Bowen R, Baetz M, Marwaha S. Mood Instability and Irritability as Core Symptoms of Major Depression: An Exploration Using Rasch Analysis. Frontiers in Psychiatry. 2016;7.
  4. 4.
    Miklowitz DJ, Weintraub MJ, Singh MK, et al. Mood Instability in Youth at High Risk for Bipolar Disorder. J Am Acad Child Adolesc Psychiatry. 2022;61(10):1285–1295.
    OpenUrl
  5. 5.↵
    Ward J, Strawbridge RJ, Bailey MES, et al. Genome-wide analysis in UK Biobank identifies four loci associated with mood instability and genetic correlation with major depressive disorder, anxiety disorder and schizophrenia. Transl Psychiatry. 2017;7(11):1264.
    OpenUrl
  6. 6.↵
    Krittanawong C, Maitra NS, Qadeer YK, et al. Association of Depression and Cardiovascular Disease. Am J Med. 2023.
  7. 7.↵
    Nakada S, Ho FK, Celis-Morales C, Jackson CA, Pell JP. Individual and joint associations of anxiety disorder and depression with cardiovascular disease: A UK Biobank prospective cohort study. Eur Psychiatry. 2023;66(1):e54.
    OpenUrl
  8. 8.↵
    Meng R, Yu C, Liu N, et al. Association of Depression With All-Cause and Cardiovascular Disease Mortality Among Adults in China. JAMA Netw Open. 2020;3(2):e1921043.
    OpenUrl
  9. 9.↵
    Wang L, Ding C. Major depression disorder may causally associate with the increased atrial fibrillation risk: evidence from two-sample mendelian randomization analyses. BMC Med Genomics. 2023;16(1):144.
    OpenUrl
  10. 10.↵
    Zwir I, Arnedo J, Del-Val C, et al. Uncovering the complex genetics of human temperament. Molecular Psychiatry. 2020;25(10):2275–2294.
    OpenUrlCrossRef
  11. 11.↵
    Kwapong YA, Boakye E, Khan SS, et al. Association of Depression and Poor Mental Health With Cardiovascular Disease and Suboptimal Cardiovascular Health Among Young Adults in the United States. J Am Heart Assoc. 2023;12(3):e028332.
    OpenUrl
  12. 12.↵
    Skrivankova VW, Richmond RC, Woolf BAR, et al. Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement. Jama. 2021;326(16):1614–1621.
    OpenUrlPubMed
  13. 13.↵
    Birney E. Mendelian Randomization. Cold Spring Harbor perspectives in medicine. 2022;12(4).
  14. 14.↵
    Davey Smith G, Ebrahim S. What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? BMJ (Clinical research ed). 2005;330(7499):1076–1079.
    OpenUrlFREE Full Text
  15. 15.↵
    Hu T, Yang F, He K, Ying J, Cui H. Association of mental health with the risk of coronary artery disease in patients with diabetes: A mendelian randomization study. Nutr Metab Cardiovasc Dis. 2022;32(3):703–709.
    OpenUrl
  16. 16.↵
    Sun J, Borne Y, Edsfeldt A, et al. Genetic Susceptibility to Mood Disorders and Risk of Stroke: A Polygenic Risk Score and Mendelian Randomization Study. Stroke. 2023;54(5):1340–1346.
    OpenUrl
  17. 17.↵
    Burgess S, Thompson SG. Avoiding bias from weak instruments in Mendelian randomization studies. International journal of epidemiology. 2011;40(3):755–764.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    Nagel M, Watanabe K, Stringer S, Posthuma D, van der Sluis S. Item-level analyses reveal genetic heterogeneity in neuroticism. Nat Commun. 2018;9(1):905.
    OpenUrl
  19. 19.
    Hartiala JA, Han Y, Jia Q, et al. Genome-wide analysis identifies novel susceptibility loci for myocardial infarction. Eur Heart J. 2021;42(9):919–933.
    OpenUrl
  20. 20.
    Shah S, Henry A, Roselli C, et al. Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure. Nat Commun. 2020;11(1):163.
    OpenUrlCrossRefPubMed
  21. 21.
    Nielsen JB, Thorolfsdottir RB, Fritsche LG, et al. Biobank-driven genomic discovery yields new insight into atrial fibrillation biology. Nature genetics. 2018;50(9):1234–1239.
    OpenUrlCrossRefPubMed
  22. 22.
    van der Harst P, Verweij N. Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease. Circulation research. 2018;122(3):433–443.
    OpenUrlAbstract/FREE Full Text
  23. 23.
    Malik R, Chauhan G, Traylor M, et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nature genetics. 2018;50(4):524–537.
    OpenUrlCrossRefPubMed
  24. 24.↵
    Hemani G, Zheng J, Elsworth B, et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife. 2018;7.
  25. 25.↵
    Yavorska OO, Burgess S. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. International journal of epidemiology. 2017;46(6):1734–1739.
    OpenUrlCrossRefPubMed
  26. 26.↵
    Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genetic epidemiology. 2013;37(7):658–665.
    OpenUrlCrossRefPubMed
  27. 27.↵
    Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. International journal of epidemiology. 2015;44(2):512–525.
    OpenUrlCrossRefPubMed
  28. 28.↵
    Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genetic epidemiology. 2016;40(4):304–314.
    OpenUrlCrossRefPubMed
  29. 29.↵
    Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nature genetics. 2018;50(5):693–698.
    OpenUrlCrossRefPubMed
  30. 30.↵
    Blumenthal JA, Rozanski A. Exercise as a therapeutic modality for the prevention and treatment of depression. Prog Cardiovasc Dis. 2023;77:50–58.
    OpenUrl
  31. 31.↵
    Popovic D, Bjelobrk M, Tesic M, et al. Defining the importance of stress reduction in managing cardiovascular disease - the role of exercise. Prog Cardiovasc Dis. 2022;70:84–93.
    OpenUrl
  32. 32.↵
    Sanderson E. Multivariable Mendelian Randomization and Mediation. Cold Spring Harbor perspectives in medicine. 2021;11(2).
  33. 33.↵
    Burgess S, Thompson SG. Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. American journal of epidemiology. 2015;181(4):251–260.
    OpenUrlCrossRefPubMed
  34. 34.↵
    Goldstein BI, Fagiolini A, Houck P, Kupfer DJ. Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. Bipolar disorders. 2009;11(6):657–662.
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    Rukh G, de Ruijter M, Schioth HB. Effect of worry, depression, and sensitivity to environmental stress owing to neurotic personality on risk of cardiovascular disease: A Mendelian randomization study. J Pers. 2023;91(3):856–867.
    OpenUrl
  36. 36.↵
    Sutkowy P, Woźniak A, Mila-Kierzenkowska C, et al. Physical Activity vs. Redox Balance in the Brain: Brain Health, Aging and Diseases. Antioxidants (Basel). 2021;11(1).
  37. 37.↵
    Lu Z, Pu C, Zhang Y, et al. Oxidative Stress and Psychiatric Disorders: Evidence from the Bidirectional Mendelian Randomization Study. Antioxidants (Basel). 2022;11(7).
  38. 38.↵
    Wang L, Bautista LE. Serum bilirubin and the risk of hypertension. International journal of epidemiology. 2015;44(1):142–152.
    OpenUrlCrossRefPubMed
  39. 39.↵
    Cohen S, Janicki-Deverts D, Doyle WJ, et al. Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proceedings of the National Academy of Sciences of the United States of America. 2012;109(16):5995–5999.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    Bunker SJ, Colquhoun DM, Esler MD, et al. “Stress” and coronary heart disease: psychosocial risk factors. The Medical journal of Australia. 2003;178(6):272–276.
    OpenUrlPubMedWeb of Science
  41. 41.↵
    Spieker LE, Hürlimann D, Ruschitzka F, et al. Mental stress induces prolonged endothelial dysfunction via endothelin-A receptors. Circulation. 2002;105(24):2817–2820.
    OpenUrlAbstract/FREE Full Text
  42. 42.↵
    Glassman AH, O’Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. Jama. 2002;288(6):701–709.
    OpenUrlCrossRefPubMedWeb of Science
  43. 43.↵
    Lespérance F, Frasure-Smith N, Koszycki D, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. Jama. 2007;297(4):367–379.
    OpenUrlCrossRefPubMedWeb of Science
  44. 44.↵
    Tsanas A, Saunders KE, Bilderbeck AC, et al. Daily longitudinal self-monitoring of mood variability in bipolar disorder and borderline personality disorder. J Affect Disord. 2016;205:225–233.
    OpenUrl
  45. 45.↵
    Song H, Fang F, Arnberg FK, et al. Stress related disorders and risk of cardiovascular disease: population based, sibling controlled cohort study. BMJ (Clinical research ed). 2019;365:1255.
    OpenUrl
  46. 46.↵
    McGowan NM, Nichols M, Bilderbeck AC, Goodwin GM, Saunders KEA. Blood pressure in bipolar disorder: evidence of elevated pulse pressure and associations between mean pressure and mood instability. Int J Bipolar Disord. 2021;9(1):5.
    OpenUrl
Back to top
Posted August 29, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Mood instability may be causally associated with the high risk of cardiovascular disease: evidence from a mendelian randomization analysis
Zirui Liu, Haocheng Wang, Zhengkai Yang, Yu Lu, Jikai Wang, Cao Zou
medRxiv 2023.08.29.23294761; doi: https://doi.org/10.1101/2023.08.29.23294761
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area